Bio-Rad Laboratories, Inc. Class A Common Stock vs Wipro Limited — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $298.3 (market cap $8.02B), while Wipro Limited trades at $1.86 (market cap $18.70B). The key difference: Wipro Limited is far larger — about 2.3× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap, and Wipro Limited pays a 10.09% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | WIT | |
|---|---|---|
Market Cap | $8.02B | $18.70B |
Sector | Health | Technology |
52-Week High | $339.75 | $3.06 |
52-Week Low | $241.71 | $1.82 |
Enterprise Value | $7.84B | $15.09B |
Dividend Yield | — | 10.09% |
Trailing returns across standard periods
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →Wipro is a leading global IT services provider, with 175,000 employees. Based in Bengaluru, this India IT services firm leverages its offshore outsourcing model to derive over half of its revenue (57%) from North America. The company offers traditional IT services offerings: consulting, managed services, and cloud infrastructure services as well as business process outsourcing as a service.
Read more on WIT →